ProfileGDS5678 / 1450451_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 29% 30% 30% 31% 29% 30% 28% 30% 29% 30% 30% 30% 33% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.6965929
GSM967853U87-EV human glioblastoma xenograft - Control 22.6785930
GSM967854U87-EV human glioblastoma xenograft - Control 32.6793230
GSM967855U87-EV human glioblastoma xenograft - Control 42.6529631
GSM967856U87-EV human glioblastoma xenograft - Control 52.618829
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.7637630
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.679628
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6609830
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6393629
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6733730
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6609530
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6577430
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.7583133
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6722630